“Should MRIs Be the First Step in Screening for Prostate Cancer?” the Omaha World-Herald headline reads. According to many of the pioneers navigating the controversial and murky waters of prostate cancer screening, the answer is yes.
Journalist Rick Ruggles interviewed CTO, Dr. Randall Jones, regarding FirstScan’s newly opened Omaha clinic. The lack of men’s health care options paired with the life-altering side effects brought about by more invasive (and oftentimes inaccurate) detection methods prompted Jones, CEO Tim Manion, and other members of the FirstScan executive team to open the clinic.
According to Ruggles’ article, “Jones said he’s more interested in better detection and care of prostate cancer than he is in making $595 per patient. He said he can earn many thousands of dollars apiece by making and fixing MRI coils in ScanMed, FirstScan’s companion business. ‘I’m not doing this just to get $595 from unsuspecting Joe Blows,’ Jones said. ‘That’s not my MO, man.’”
Ruggles also mentions that prostate MRIs are picking up steam outside of the US. England’s National Health Service recommends an MRI after a man shows an elevated PSA. A study in Sweden is also currently in full swing to see how much MRIs improve detection.
To read the full article, click Here.